Xiaojie Chu
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Microbiology top 5%
- Bacterial Infections and Vaccines
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 9
-
- Immunotherapy and Immune Responses 4
- Immune Cell Function and Interaction 3
- Galectins and Cancer Biology 2
- Co-authors
- Cunbao Liu (10 shared papers)Weiwei Huang (8 shared papers)Wenjia Sun (8 shared papers)Yang Li (7 shared papers)Yufeng Yao (5 shared papers)Yanbing Ma (4 shared papers)Qiong Long (5 shared papers)Xu Yang (6 shared papers)
- Journals
- Human Vaccines & Immunotherapeutics (3 papers)Scientific Reports (2 papers)Molecular Pharmaceutics (1 paper)Molecular Therapy — Oncolytics (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Xiaojie Chu
18 papers receiving 494 citations
Peers
Comparison fields: 5 of 61
- Molecular Medicine 162
- Microbiology 161
- Endocrinology 107
- Immunology 148
- Epidemiology 126
Countries citing papers authored by Xiaojie Chu
This map shows the geographic impact of Xiaojie Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojie Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojie Chu more than expected).
Fields of papers citing papers by Xiaojie Chu
This network shows the impact of papers produced by Xiaojie Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojie Chu. The network helps show where Xiaojie Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaojie Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 102 | |
| 2 | 2016 | 101 | |
| 3 | 2016 | 99 | |
| 4 | 2018 | 32 | |
| 5 | 2016 | 31 | |
| 6 | 2017 | 25 | |
| 7 | 2021 | 19 | |
| 8 | 2014 | 18 | |
| 9 | 2019 | 18 | |
| 10 | 2023 | 12 | |
| 11 | 2023 | 9 | |
| 12 | 2017 | 9 | |
| 13 | 2018 | 7 | |
| 14 | 2023 | 6 | |
| 15 | 2023 | 4 | |
| 16 | 2023 | 3 | |
| 17 | 2025 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2024 | 0 | |
| 20 | 2025 | 0 |
About Xiaojie Chu
Xiaojie Chu is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Molecular Biology, Epidemiology and Oncology, having authored 20 papers that have together received 497 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), Immunotherapy and Immune Responses (4 papers), Hepatitis B Virus Studies (3 papers), Immune Cell Function and Interaction (3 papers), Galectins and Cancer Biology (2 papers), Escherichia coli research studies (2 papers), Glycosylation and Glycoproteins Research (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Molecular Medicine (162 citations), Microbiology (161 citations), Endocrinology (107 citations), Immunology (148 citations) and Epidemiology (126 citations). Xiaojie Chu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Cunbao Liu, Weiwei Huang, Wenjia Sun, Yang Li, Yufeng Yao, Yanbing Ma, Qiong Long, Xu Yang, Ye Xia and Hongmei Bai. Their work appears in journals such as Human Vaccines & Immunotherapeutics, Scientific Reports, Molecular Pharmaceutics, Molecular Therapy — Oncolytics and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.